Life Science Connect Blog

  1. Big Pharma “Fountain Of Youth” Drug, FDA Approvals, And Other Pharma News 1/7/2015

    In the news recently, we may be closer to slowing aging with a new “Fountain of Youth” drug; two phase 3 clinical trials have reported developments in schizophrenia and female sexual disorder; and the FDA’s 2014 drug approval record has turned some heads.

  2. Merck Snaps Up Cubist: Will 2015 Be The Antibiotics Renaissance? 1/7/2015

    2014 was a big year for acquisitions. However, two other 2014 acquisitions suggest to me that Big Pharma might be planning to tackle an increasingly urgent unmet health need in 2015.

  3. Has AbbVie Started A Hep C Drug Pricing Revolution? 1/7/2015

    Right before the holidays, the FDA gave a nod to Viekira Pak, a new AbbVie drug cocktail credited with curing over 90 percent of those with genotype 1 hep C. Overall, it was a considerable year for HCV treatments. . 2014 was also the year of the “Great Pricing Wars.” 

  4. Will BRICS Have Answers To The HIV Vaccine Search? 1/7/2015

    At the beginning of December, Russia announced it was pushing not just one, but three new HIV vaccines into clinical trials. But Russia is not the only country searching for a successful HIV vaccine as we venture into 2015.